高雄醫學大學圖書館 |

語系/ Language: 繁體中文

登入

回首頁

New generation of antipsychotic drug...

Mendlewicz, J.

New generation of antipsychotic drugs : novel mechanisms of action : workshop, Monte Carlo, March 16-18, 1992

紀錄類型:	書目-語言資料,印刷品 : 單行本
劃一題名:	International Academy for Biomedical and Drug Research (Series)
副題名:	novel mechanisms of action : workshop, Monte Carlo, March 16-18, 1992
合作者:	Mendlewicz, J.
合作者:	Racagni, Giorgio.
合作者:	Brunellio, Nicoletta.
出版地:	Basel
出版者:	Karger;
出版年:	1993.
面頁冊數:	150 p.ill. : 25 cm.;
集叢名:	International Academy for Biomedical and Drug Research
標題:	Antipsychotic Agents - pharmacology -
ISBN:	3805556543
內容註:	(cont.) Future strategies in the discovery of new antipsychotic agents: focus on dopamine-glutamate interactions / A. Carlsson, A. Svensson, M.L. Carlsson -- Dopamine (D b2 s)-receptor occupancy in clozapine-treated patients as measured by positron emission tomography using p18 sFESP / J.W. Louwerens ... [et al.] -- Negative symptomatology and the therapeutic use of benzamides / P. Boyer, Y. Lecrubier -- Treatment of schizophrenia: cost- and risk-benefit issues. Panel discussion.
內容註:	Multiple dopamine receptors as molecular targets for antipsychotics / J.-C. Schwartz ... [et al.] -- Nondopaminergic mechanisms relevant to antipsychotic activity / Z.N. Stowe, B.C. Nemeroff -- What are atypical neuroleptics and how do they work? / D.M. Jackson ... [et al.] -- Origins of psychosis and the evolution of human language and communication / T.J. Crow -- Pharmacology of sertindole, a novel atypical neuroleptic / T. Skarsfeldt -- Nontarget actions of neuroleptics, neuroleptic side effects and tardive dyskinesia / C.A. Tamminga, O. Shirakawa, R.R. Conley -- Pharmacological and psychosocial long-term treatment of schizophrenia / S. Hirsch -- Clinical-biochemical investigations with classical and nonclassical neuroleptics / M. Ackenheil -- Remoxipride and haloperidol in acute phase schizophrenia: experiences from a recent clinical trial programme / T. Lewander ... [et al.] -- Utilization, multidimensional outcome measures, and risk-benefit considerations for the use of clozapine in schizophrenia / H.Y. Meltzer.

New generation of antipsychotic drugs : novel mechanisms of action : workshop, Monte Carlo, March 16-18, 1992
New generation of antipsychotic drugs : novel mechanisms of action : workshop, Monte Carlo, March 16-18, 1992 / volume editors, N. Brunello, J. Mendlewicz, G. Racagni. - Basel : Karger, 1993.. - 150 p. ; ill. ; 25 cm.. - (International Academy for Biomedical and Drug Research ; vol. 4.).
(cont.) Future strategies in the discovery of new antipsychotic agents: focus on dopamine-glutamate interactions / A. Carlsson, A. Svensson, M.L. Carlsson -- Dopamine (D b2 s)-receptor occupancy in clozapine-treated patients as measured by positron emission tomography using p18 sFESP / J.W. Louwerens ... [et al.] -- Negative symptomatology and the therapeutic use of benzamides / P. Boyer, Y. Lecrubier -- Treatment of schizophrenia: cost- and risk-benefit issues. Panel discussion.Multiple dopamine receptors as molecular targets for antipsychotics / J.-C. Schwartz ... [et al.] -- Nondopaminergic mechanisms relevant to antipsychotic activity / Z.N. Stowe, B.C. Nemeroff -- What are atypical neuroleptics and how do they work? / D.M. Jackson ... [et al.] -- Origins of psychosis and the evolution of human language and communication / T.J. Crow -- Pharmacology of sertindole, a novel atypical neuroleptic / T. Skarsfeldt -- Nontarget actions of neuroleptics, neuroleptic side effects and tardive dyskinesia / C.A. Tamminga, O. Shirakawa, R.R. Conley -- Pharmacological and psychosocial long-term treatment of schizophrenia / S. Hirsch -- Clinical-biochemical investigations with classical and nonclassical neuroleptics / M. Ackenheil -- Remoxipride and haloperidol in acute phase schizophrenia: experiences from a recent clinical trial programme / T. Lewander ... [et al.] -- Utilization, multidimensional outcome measures, and risk-benefit considerations for the use of clozapine in schizophrenia / H.Y. Meltzer..
Includes bibliographical references and index..
ISBN 3805556543
Antipsychotic Agents -- pharmacology

Mendlewicz, J.

New generation of antipsychotic drugs : novel mechanisms of action : workshop, Monte Carlo, March 16-18, 1992
LDR:02363cam0 2200241 i 450 001 276147
005 20170311210641.0
009 269856
010 $a 3805556543 $b 平裝 $d NT500
020 $b 92049069
100 $a 20140812d m00y1chib5050 e
200 $a New generation of antipsychotic drugs $e novel mechanisms of action : workshop, Monte Carlo, March 16-18, 1992 $f volume editors, N. Brunello, J. Mendlewicz, G. Racagni.
210 $a Basel $a New York $d 1993. $c Karger
215 $a 150 p. $c ill. $d 25 cm.
225 $a International Academy for Biomedical and Drug Research $v vol. 4.
320 $a Includes bibliographical references and index.
327 $a (cont.) Future strategies in the discovery of new antipsychotic agents: focus on dopamine-glutamate interactions / A. Carlsson, A. Svensson, M.L. Carlsson -- Dopamine (D b2 s)-receptor occupancy in clozapine-treated patients as measured by positron emission tomography using p18 sFESP / J.W. Louwerens ... [et al.] -- Negative symptomatology and the therapeutic use of benzamides / P. Boyer, Y. Lecrubier -- Treatment of schizophrenia: cost- and risk-benefit issues. Panel discussion.
327 $a Multiple dopamine receptors as molecular targets for antipsychotics / J.-C. Schwartz ... [et al.] -- Nondopaminergic mechanisms relevant to antipsychotic activity / Z.N. Stowe, B.C. Nemeroff -- What are atypical neuroleptics and how do they work? / D.M. Jackson ... [et al.] -- Origins of psychosis and the evolution of human language and communication / T.J. Crow -- Pharmacology of sertindole, a novel atypical neuroleptic / T. Skarsfeldt -- Nontarget actions of neuroleptics, neuroleptic side effects and tardive dyskinesia / C.A. Tamminga, O. Shirakawa, R.R. Conley -- Pharmacological and psychosocial long-term treatment of schizophrenia / S. Hirsch -- Clinical-biochemical investigations with classical and nonclassical neuroleptics / M. Ackenheil -- Remoxipride and haloperidol in acute phase schizophrenia: experiences from a recent clinical trial programme / T. Lewander ... [et al.] -- Utilization, multidimensional outcome measures, and risk-benefit considerations for the use of clozapine in schizophrenia / H.Y. Meltzer.
500 $a International Academy for Biomedical and Drug Research (Series) $3 353870
606 $a Antipsychotic Agents $x pharmacology $x congresses. $3 353871
676 $a 615.7882 $v 20
680 $a RM333.5 $b .N48 1993
686 $a WM100 $b M538
687 $a W1 $b IN701D v.4 1993
687 $a QV 77.9QV77.9 $b N42g 1993
701 $a Mendlewicz, J. $3 353867
701 $a Racagni, Giorgio. $3 353868
701 $a Brunellio, Nicoletta. $3 353869
801 $a DNLM/DLC $c DLC $g NLM $g EET $b K000